期刊文献+

血清GP73、AFP-L3、AFP、AFU检测在原发性肝癌诊断中的临床价值 被引量:10

下载PDF
导出
摘要 目的探讨血清高尔基体蛋白73(GP73)、甲胎蛋白异质体(AFP-L3)、甲胎蛋白(AFP)、α-L-岩藻糖苷酶(AFU)检测在原发性肝癌诊断中的临床价值。方法在医院2016年7月-2017年7月诊治的原发性肝癌患者中选取56例作研究对象,同期选取56例健康体检者作为对照组,对两组受检者进行血清GP73、AFP-L3、AFP、AFU检测,就2组受检者进行血清GP73、AFP-L3、AFP、AFU水平差异统计学分析。结果研究组受检者的血清GP73、AFP-L3、AFP、AFU水平均远高于对照组,且四项血清标志物组间比较差异有统计学意义(均P<0.05)。结论血清GP73、AFP-L3、AFP、AFU检测在原发性肝癌诊断中的临床价值显著,可准确诊断本病,值得借鉴。
作者 高强
出处 《航空航天医学杂志》 2019年第1期41-42,共2页 Journal of Aerospace medicine
  • 相关文献

参考文献5

二级参考文献44

  • 1Bertino G, Ardiri A, Malaguarnera M, et al. Hepatocelluar carcinoma serum markers. Semin 0ncol,2012,39 (4) :410-433.
  • 2Mao Y, Yang H, Xu H, et al. Golgi protein 73 ( GOLPH2 ) is a valuable serum marker for hepatocellular carcinoma. Gut,2010,59 (12) : 1687-1693.
  • 3Toyoda H, Kumada T, Tada T, et al. Tumor markers for hepatocellular carcinoma: simple and significant predictors of outcome in patients with HCC [ J 1- Liver Cancer, 2015, 4 (2) : 126-136.
  • 4Ge T, Shen Q, Wang N, et al. Diagnostic values of alpha- fetoprotein, dickkopf-1, and osteopontin for hepatocellular carcinoma~J]. Med Oncol, 2015,32(3): 367.
  • 5Xu WJ, Guo BL, Han YG, eta|. Diagnostic value of alpha- fetoprotein-L3 and Golgi protein 73 in hepatocellular carcinomas with low AFP levels[J]. Tumor Biol, 2014,35 (12) : 12069- 12074.
  • 6Facciorusso A, Del Prete V, Antonino M, et al. Serum Ferritin as a new prognostic factor in hepatocellular carcinoma patients treated with radiofrequency ablation[ J]. J Gastroenterol Hepatol, 2014, 29(11): 1905-1910.
  • 7Toyoda H, Kumada T, Tada T, et al. Prognostic significance of a combination of pre- and post-treatment tumor markers for hepatocellular carcinoma curatively treated with hepatectomy [ J ]. J Hepatol, 2012,57(6) : 1251-1257.
  • 8Hu B, Tian X, Sun J, et al. Evaluation of individual and combined applications of serum biomarkers for diagnosis of hepatocellular carcinoma: a meta-analysis [ J ]. Int J Mo| Sci, 2013,14(12) : 23559-23580.
  • 9Uchino K, Tateishi R, Fujiwara N, et al. Impaet of serum ferritin level on hepatocarcinogenesis in chronic hepatitis C patients [ J ]. Hepatol Res, 2016, 46 (4) : 259-268.
  • 10Uchino K, Tateishi R, Fujiwara N, et al. hnpact of serum fen'itin level on hepatocarcinogenesis in chronic hepatitis C patients [ J ]. Hepatol Res, 2016, 46 (4) : 259-268.

共引文献124

同被引文献121

引证文献10

二级引证文献75

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部